Prenatal & Maternal Diagnostic Market Landscape Investigated in In-demand Study by Kelly Scientific Publications Available at MarketPublishers.com
28 Feb 2017 • by Natalie Aster
LONDON – Approximately 140 million babies are born annually, out of which nearly 5 million die in the 1st month of life, especially in developing countries. For instance, in India, 5-15% of sick newborns suffer from a metabolic disorder. This underlines the need for newborn screening, which could help to prevent disability and death by early intervention.
Today, the usage of ultrasound imaging and maternal serum maker screening for the detection of various birth defects form an integral part of prenatal care in the two first trimesters. However, still both these techniques have certain disadvantages of high false positive rates. If these tests show any possibility of increased risk of aneuploidy, then invasive approaches like chorionic villus sampling or amniocentesis are suggested for diagnosis.
In-demand topical study “Global Prenatal & Maternal Diagnostic Market to 2021” prepared by Kelly Scientific Publications offers a detailed guide to the global prenatal and maternal diagnostic market landscape and discloses trustworthy qualitative and also quantitative info on the market performance (historical, present and projected). This study highlights the existing diagnosis techniques, covers the recent industry developments and product launches, identifies the unmet needs and emerging treats and opportunities, discusses the major factors influencing the prenatal and maternity diagnostics market development and growth. The report touches upon the prevailing trends and regulative norms, delves into competitive landscape and identifies the most prominent players and also presents forecasts for the market up till 2021.
Many other in-demand research reports worked out by this publisher are available in the Kelly Scientific Publications catalogue at MarketPublishers.com.